0001209191-15-072818.txt : 20151001
0001209191-15-072818.hdr.sgml : 20151001
20151001173942
ACCESSION NUMBER: 0001209191-15-072818
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150930
FILED AS OF DATE: 20151001
DATE AS OF CHANGE: 20151001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151137968
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-30
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-09-30
4
M
0
10400
35.64
A
355684
D
Common Stock
2015-09-30
4
S
0
3700
102.24
D
351984
D
Common Stock
2015-09-30
4
S
0
4040
103.20
D
347944
D
Common Stock
2015-09-30
4
S
0
2260
104.15
D
345684
D
Common Stock
2015-09-30
4
S
0
400
105.13
D
345284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
35.64
2015-09-30
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
177600
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $102.24 (range $101.74 to $102.72).
Open market sales reported on this line occurred at a weighted average price of $103.20 (range $102.74 to $103.73).
Open market sales reported on this line occurred at a weighted average price of $104.15 (range $103.76 to $104.75).
Open market sales reported on this line occurred at a weighted average price of $105.13 (range $105.11 to $105.16).
Fully vested.
Omar White, Attorney-In-Fact
2015-10-01